Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07487649

Treatment Response in Patients With Medication-Overuse Headache

Factors Affecting Treatment Response in Patients With Medication-Overuse Headache Undergoing Greater Occipital Nerve Blockade

Status
Recruiting
Phase
Study type
Observational
Enrollment
70 (estimated)
Sponsor
Sultan 1. Murat State Hospital · Other Government
Sex
All
Age
18 Years – 65 Years
Healthy volunteers

Summary

The aim of this study to evaluate pre-injection patient-related factors that may influence treatment response in patients with medication-overuse headache who underwent ultrasound-guided greater occipital nerve block.

Conditions

Interventions

TypeNameDescription
OTHERTreatment outcomeBefore the injection, patients will be evaluated for the number of headache days, headache severity, the number of days of analgesic use for headache, headache-related disability, pressure pain threshold over the bilateral greater occipital nerve, anxiety and depression scores, and sleep quality. At 1 and 2 months after the injection, they will be reassessed for the number of headache days, headache severity, and the number of days of analgesic use for headache. In addition, at 1 hour after the injection, the pain experienced during the injection procedure will be assessed.

Timeline

Start date
2026-03-17
Primary completion
2026-05-30
Completion
2026-05-30
First posted
2026-03-23
Last updated
2026-03-23

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07487649. Inclusion in this directory is not an endorsement.